An organotypic slice culture model of chronic white matter injury with maturation arrest of oligodendrocyte progenitors
© Dean et al; licensee BioMed Central Ltd. 2011
Received: 11 May 2011
Accepted: 5 July 2011
Published: 5 July 2011
CNS myelination disturbances commonly occur in chronic white matter lesions in neurodevelopmental and adult neurological disorders. Recent studies support that myelination failure can involve a disrupted cellular repair mechanism where oligodendrocyte (OL) progenitor cells (OPCs) proliferate in lesions with diffuse astrogliosis, but fail to fully differentiate to mature myelinating OLs. There are no in vitro models that reproduce these features of myelination failure.
Forebrain coronal slices from postnatal day (P) 0.5/1 rat pups were cultured for 1, 5, or 9 days in vitro (DIV). Slices rapidly exhibited diffuse astrogliosis and accumulation of the extracellular matrix glycosaminoglycan hyaluronan (HA), an inhibitor of OPC differentiation and re-myelination. At 1 DIV ~1.5% of Olig2+ OLs displayed caspase-3 activation, which increased to ~11.5% by 9 DIV. At 1 DIV the density of PDGFRα+ and PDGFRα+/Ki67+ OPCs were significantly elevated compared to 0 DIV (P < 0.01). Despite this proliferative response, at 9 DIV ~60% of white matter OLs were late progenitors (preOLs), compared to ~7% in the postnatal day 10 rat (P < 0.0001), consistent with preOL maturation arrest. Addition of HA to slices significantly decreased the density of MBP+ OLs at 9 DIV compared to controls (217 ± 16 vs. 328 ± 17 cells/mm2, respectively; P = 0.0003), supporting an inhibitory role of HA in OL lineage progression in chronic lesions.
Diffuse white matter astrogliosis and early OPC proliferation with impaired OL maturation were reproduced in this model of myelination failure. This system may be used to define mechanisms of OPC maturation arrest and myelination failure related to astrogliosis and HA accumulation.
Disturbances in CNS myelination are a central feature of numerous neurodevelopmental and adult neurological disorders, and are widely recognized to occur in areas of reactive astrogliosis. Although myelination disturbances frequently involve oligodendrocyte (OL) degeneration [1–3], emerging evidence supports that OL progenitor cells (OPCs) exhibit a robust regenerative response to injury. In chronic white matter lesions, OPCs proliferate but fail to fully differentiate to mature myelinating OLs, supporting the concept that failure to generate new myelin is related to arrest of oligodendrocyte maturation [4–6].
The mechanisms that mediate inhibition of OL maturation following CNS insults are largely unknown. Reactive astrogliosis is linked to OPC maturation arrest and remyelination failure in a number of conditions [7–9], and both Notch signaling and bone morphogenetic proteins induced during reactive gliosis have been implicated in these inhibitory processes [10, 11]. Release of hyaluronan (HA) by reactive astrocytes also appears to be an important regulator of CNS myelination , and HA can arrest OPC maturation both in vitro and in vivo [13, 14]. HA is a non-sulfated, protein-free glycosaminoglycan that forms an integral part of the extracellular matrix. In the CNS, HA is predominantly synthesized by astrocytes, and can accumulate in areas of chronic astrocytosis and myelination disturbance . HA and its receptor CD44 are robustly expressed in white matter lesions with diffuse astrogliosis, consistent with the response observed in demyelinating lesions, traumatic spinal cord injury, vascular brain injury associated with dementia, and ischemic lesions in adult humans and rodents [14, 16, 17]. The molecular mechanisms by which HA inhibits OL maturation are largely unknown, and as yet, there are no well-established in vitro models that reproduce the major features of chronic white matter lesions.
Herein, we developed a slice culture model of reactive astrogliosis that exhibited accumulation of HA in the white matter, with associated OPC proliferation but impaired maturation. Addition of HA to this system further impaired OPC maturation, providing support for an inhibitory role of HA in OL lineage progression. This chronic white matter injury model thus provides a novel system to define mechanisms of myelination failure related to astrogliosis and disturbances in oligodendrocyte maturation.
Organotypic slice cultures display progressive diffuse astrogliosis and HA accumulation
Next, we detected HA expression with a biotinylated hyaluronan (HA) binding protein (bHABP). At 0 DIV (Figure 1I), there was low HA expression in the white matter, followed by a progressive increase from 1 DIV to 9 DIV (Figure 1J-L). Elevated HA was observed predominantly in areas of gliosis (Figure 1M-O), with a characteristic pericellular pattern of expression (Figure 1P), consistent with previous observations . Hence, chronic slice cultures displayed diffuse astrogliosis and HA accumulation similar to that observed in chronic cerebral whiter matter lesions in vivo.
Oligodendrocyte (OL) survival and progenitor responses in white matter of organotypic slice cultures
To examine the response of OPCs in the white matter of this slice culture model, we examined the density of PDGFRα+ OPCs and their co-localization with the proliferation marker Ki67 at 0 DIV, 1 DIV, 5 DIV and 9 DIV (Figure 2C). At 1 DIV, there was a significant increase in the density of both PDGFRα+ cells and PDGFRα+/Ki67+ double-labeled cells compared to 0 DIV (ANCOVA + Tukey's test; P < 0.01, for both), consistent with OPC proliferation. By 5 DIV and 9 DIV the density of both PDGFRα+ cells and PDGFRα+/Ki67+ double-labeled cells returned to 0 DIV levels. With increasing time in culture, PDGFRα+ OPCs exhibited a reactive-type of morphology, with increased cell body size and process thickness, as well as more extensive process arborization and complexity (Figure 2D-F). Hence, this slice culture model was associated with an acute phase of rapid OPC proliferation resulting in a net expansion in the OPC pool, followed by a delayed phase of degeneration.
Delayed OPC maturation in white matter of organotypic slice cultures
To determine the timing of OPC maturation, we quantified the relative percentages of late oligodendrocyte precursors (preOLs; O4+/O1-) and immature oligodendrocytes (immature OLs; O4+/O1+) in slice cultures at 9 DIV compared to the normal rat brain at an equivalent postnatal age (P10). Rat brains at P10 only expressed 7 ± 2% preOLs in the white matter (Figure 3A, E). Most O4+/O1+ immature OLs displayed a reduced process arbor and extensive early myelination (Figure 3C). By contrast, there were 60 ± 1% preOLs in the white matter in this slice culture model at 9 DIV (Figure 3B, E; P < 0.0001). Interestingly, both preOLs and immature OLs displayed a reactive morphology, with a hypertrophic cell body and an extensive arbor of processes (Figure 3D) relative to normal brain at P10 (Figure 3C). Some O4+/O1+ OLs showed a highly branched morphology consistent with mature OLs (Figure 3F). Hence, the maturation of OPCs in this slice model was markedly delayed relative to the normal rat brain, with arrested OL maturation at the preOL stage.
Timing of myelin onset in white matter of organotypic slice cultures
Exogenous hyaluronan impairs oligodendrocyte maturation in white matter of organotypic slice cultures
The normal regulation of oligodendrocyte (OL) maturation and myelination in the CNS is critical for normal vertebrate function, as well as to promote recovery following white matter injury. Dissociated OL cultures have provided important information on many aspects of these processes. Nevertheless, there are no well-established in vitro models that accurately model the chronic gliotic lesions often observed in disorders with myelination failure. There is now increasing interest in the use of organotypic slice cultures for studies of OL biology and myelination due to retention of multi-cellular interactions and the ease of manipulation [20–22]. However, we found that organotypic slice cultures display features consistent with a chronic white matter injury in vivo, which included white matter gliosis, cell death, OPC proliferative and reactive responses and arrested OL lineage maturation. Hence, when employing a chronic slice culture model for studies of normal oligodendroglial biology or myelination, these chronic injury responses should be considered.
Similar to recent in vivo studies examining the chronic OL response to white matter injury, we found rapid and progressive reactive astrocytosis and microglia/macrophage accumulation in the white matter of slice cultures, as well as an early proliferative response of OPCs. This expanded pool of OPCs exhibited a reactive morphology, delayed OL degeneration, and impaired maturation of preOLs to OLs. Delayed OPC maturation did not appear to be region-specific and cortical OPC maturation by 9 DIV also was delayed relative to the extensive myelination that occurs in vivo by postnatal day 10. These in vitro responses are very similar to those first described in neonatal rodents following hypoxia-ischemia, where despite extensive OL degeneration, there was a rapid proliferative response of OPCs, subsequent failure of preOLs to mature in chronic astrogliotic lesions, and persistent myelination deficits . A role for OL maturation arrest in developmental myelination disturbance is supported by more recent studies in preterm fetal sheep following hypoxia-ischemia  and in preterm human autopsy cases with chronic white matter injury (Buser et al., submitted). OPCs also accumulate but fail to mature to myelinating OLs in chronic demyelinated lesions in multiple sclerosis patients [24–26]. In a recent postmortem study of brains from human cases of age-related cognitive decline associated with vascular brain injury, a significant increase in the total pool of OLs was correlated with changes in MRI-defined diffusion characteristics consistent with white matter myelin deficits .
Our slice culture system exhibited a progressive increase in expression of HA in the white matter with time in culture, while addition of exogenous HA further inhibited OL maturation. These data suggest a role for endogenously released HA in mediating the impairment of OL maturation observed in this system, and support previous studies where addition of HA reversibly impaired maturation of cultured OPCs and inhibited remyelination after lysolethicin-induced white matter demyelination [13, 14]. Accumulation of HA was also reported following traumatic spinal cord injury  and middle cerebral artery occlusion  in adult rats, and in stroke-affected brain regions in adult humans , although myelination deficits were not examined. The increase in white matter HA in the slice cultures was likely a response to the reactive astrogliosis, because in the CNS, HA is predominantly produced by astrocytes ; however, we cannot discount a role of other CNS glia. The reactive gliosis observed in this system was likely a response to neuronal and glial degeneration secondary to generation of the tissue slices.
This model provides a novel system to define mechanisms that regulate disturbances in oligodendrocyte maturation and myelination failure related to chronic CNS astrogliosis. Future studies will utilize this model to determine the signaling pathways by which HA regulates oligodendrocyte development in the setting of chronic white matter injury.
Postnatal brain slice preparation and culture
All animal procedures were approved by the OHSU Institutional Animal Care and Use Committee (IACUC) according to the NIH Guide for the Care and Use of Laboratory Animals. Timed pregnant Sprague-Dawley (SD) rats were purchased from Charles River (Hollister, CA, USA). Whole forebrain coronal slices (300 μm; collected at the level of the rostral corpus callosum and anterior septal nuclei; 3 adjacent slices from each brain) collected from postnatal day (P) 0.5/1 rat pups were used to prepare organotypic cultures according to a previous method , with modifications. Brains were embedded in 1.5% low melting point agar (Fischer Scientific, Fair Lawn, NJ, USA) and sectioned into sterile ice-cold complete Hank's balanced salt solution (HBSS, Ca2+/Mg2+ free [Invitrogen Co., Carlsbad, USA], supplemented with D-glucose [30 mM), HEPES buffer [2.5 mM], CaCl2 [1 mM], MgSO4 [1 mM], NaHCO3 [4 mM], and 0.001% phenol red [Sigma-Aldrich Co., St. Louis, MO, USA]) using a VTS 1600 vibrating microtome (Leica Microsystems Inc., Buffalo Grove, USA). Isolated slices were transferred onto 0.4 μm porous membrane cell culture inserts (Becton Dickinson, Franklin Lakes, NJ, USA) that were pre-coated with laminin/poly-D-lysine (Sigma-Aldrich Co.), and cultured in slice culture media (Basal Medium Eagle [Invitrogen Co.], supplemented with complete HBSS [25% v/v], D-glucose [27 mM], penicillin [100 U/mL], streptomycin [100 U/mL], glutamine [1 mM; Sigma-Aldrich Co.], and 5% horse serum [New Zealand origin, heat inactivated; Invitrogen Co.]). Slices were incubated at 37°C/5% CO2, and the growth medium changed daily. In pilot experiments we determined that 5% serum resulted in optimal acute survival of the slices when compared to 25% serum, as previously reported .
Time course experiments
Slices were collected at 1, 5, 9, or 13 days in vitro (DIV), fixed in 4% paraformaldehyde (PFA; 0.1 M phosphate buffered saline [PBS]) for 1 h at RT, and washed thoroughly in PBS prior to immunohistochemical staining. As controls, slices were fixed immediately after cutting (0 DIV; i.e., no culture).
High molecular weight hyaluronan (1.59 × 106 Da; Seikagaku Co., Tokyo, Japan) was dissolved in sterile PBS (5 mg/mL), and then added daily to fresh slice growth medium (final concentration, 100 μg/mL) from 0 DIV until 9 DIV . Slices were then processed for immunohistochemistry as described.
Antibodies and markers
Biotinylated hyaluronan binding protein (bHABP)
Associates of Cape Cod, Inc., East Falmouth, MA
Cleaved caspase-3 (CC3)
Cell Signaling Technology, Danvers, MA
Dako North America, Inc., Carpinteria, CA
Wako Chemicals USA Inc., Richmond, VA
Cell Cycle Activation
Novocastra, Buffalo Grove, IL
Covance, Princeton, NY
Monoclonal mouse IgM
Dr. Rashmi Bansal (University of Connecticut Health Center, Farmington, CT)
Monoclonal mouse IgM
Late OL progenitor/immature OL
Research Genetics, Huntsville, AL
R&D Systems, Minneapolis, MN
Dr. John Alberta (Dana-Farber Cancer Institute, Boston, MA
The white matter of cultured slices was analyzed using a Leica DMIRE2 inverted fluorescence microscope (Leica Microsystems Inc., Buffalo Grove, IL, USA) coupled to a Stereoinvestigator stereology system (MBF Bioscience, Williston, VT, USA). For each slice, the entire white matter (defined by DAPI-staining) region of interest (ROI) was traced at 5 × magnification. Using the software to maintain white matter boundaries, cell counts were performed using the optical fractionator probe (Grid size, 300 × 400 μm; Counting frame, 30 × 30 μm; z-depth 20 μm) at 40 × magnification in a minimum of 10 randomly selected white matter fields per slice. The slice thickness was also measured at each counting site. Cell density (mm2) was calculated by the formula: [cell counts/(number of fields × counting frame area (mm2))].
An unpaired two-tailed t-test was used to compare percentage OLs between normal rat brain and the slice cultures. One-way analysis of variance (ANOVA) followed by Tukey's multiple comparison test was used to assess changes in percentage CC3+ OLs in the white matter over time in culture. To determine the effect of slice atrophy on PDGFRα cell density measurements, we quantified mean white matter volume. For each slice, white matter volume was calculated from white matter ROI area × mean white matter thickness (determined from all count sites) as acquired during cell counting. One-way analysis of variance (ANOVA) followed by Tukey's multiple comparison test was first run to determine relative atrophy with time in culture. There was a significant overall effect of group (P < 0.01), with a significant decrease in white matter volume at 5 DIV and 9 DIV compared to other ages (white matter volume, mm3: 0 DIV, 0.26 mm3; 1 DIV, 0.29 mm3; 5 DIV, 0.18 mm3; 9 DIV, 0.18 mm3; P < 0.05), which was attributed to a shrinkage of the white matter ROI area rather than in the z-plane of the slice (data not shown). Because of this reduction in white matter volume, we accounted for degree of atrophy by using white matter volume as a covariate when comparing cell density measurements between time in culture using a one-way analysis of covariance (ANCOVA) followed by Tukey's multiple comparison test. Cell density data were presented uncorrected for atrophy. A P-value less than 0.05 was considered statistically significant. All data are presented as mean ± standard error of the mean (SEM), with significance indicated for both ANOVA and ANCOVA analyses (For figure 2, *P < 0.01 refers to analysis of uncorrected data by ANOVA; †P < 0.01 refers to analysis of data corrected for slice atrophy by ANCOVA).
Supported by the National Institutes of Neurological Diseases and Stroke: 1RO1NS054044, R37NS045737-06S1/06S2 to SAB and 1F30NS066704 to AR, a Bugher Award from the American Heart Association (SAB) and the March of Dimes Birth Defects Foundation (SAB). LS was supported by NIH core grant RR00163 supporting the Oregon National Primate Research Center. JD was supported by a Heubner Family Developmental Neurobiology of Disease Fellowship. The Olig2 antibodies were a generous gift of Dr. John Alberta. AB was supported by NIMH grant K01MH08025.
- Wilke S, Thomas R, Allcock N, Fern R: Mechanism of acute ischemic injury of oligodendroglia in early myelinating white matter: the importance of astrocyte injury and glutamate release. J Neuropath Exp Neurol. 2004, 63: 872-881.PubMedView ArticleGoogle Scholar
- Back SA, Luo NL, Mallinson RA, O'Malley JP, Wallen LD, Frei B, Morrow JD, Petito CK, Roberts CT, Murdoch GH, Montine TJ: Selective vulnerability of preterm white matter to oxidative damage defined by F2-isoprostanes. Ann Neurol. 2005, 58: 108-120. 10.1002/ana.20530.PubMedView ArticleGoogle Scholar
- Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, Arvin KL, Holtzman DM: Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci. 2002, 22: 455-463.PubMedGoogle Scholar
- Segovia KN, McClure M, Moravec M, Luo NL, Wan Y, Gong X, Riddle A, Craig A, Struve J, Sherman LS, Back SA: Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injury. Ann Neurol. 2008, 63: 520-530. 10.1002/ana.21359.PubMedPubMed CentralView ArticleGoogle Scholar
- Fancy SP, Kotter MR, Harrington EP, Huang JK, Zhao C, Rowitch DH, Franklin RJ: Overcoming remyelination failure in multiple sclerosis and other myelin disorders. Exp Neurol. 2010, 225: 18-23. 10.1016/j.expneurol.2009.12.020.PubMedView ArticleGoogle Scholar
- Huang Z, Liu J, Cheung PY, Chen C: Long-term cognitive impairment and myelination deficiency in a rat model of perinatal hypoxic-ischemic brain injury. Brain Res. 2009, 1301: 100-109.PubMedView ArticleGoogle Scholar
- Skripuletz T, Bussmann JH, Gudi V, Koutsoudaki PN, Pul R, Moharregh-Khiabani D, Lindner M, Stangel M: Cerebellar cortical demyelination in the murine cuprizone model. Brain Pathol. 2010, 20: 301-312. 10.1111/j.1750-3639.2009.00271.x.PubMedView ArticleGoogle Scholar
- Anderson JM, Hampton DW, Patani R, Pryce G, Crowther RA, Reynolds R, Franklin RJ, Giovannoni G, Compston DA, Baker D, Spillantini MG, Chandran S: Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis. Brain. 2008, 131: 1736-1748. 10.1093/brain/awn119.PubMedView ArticleGoogle Scholar
- Keirstead HS, Nistor G, Bernal G, Totoiu M, Cloutier F, Sharp K, Steward O: Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. The J Neurosci. 2005, 25: 4694-4705. 10.1523/JNEUROSCI.0311-05.2005.PubMedView ArticleGoogle Scholar
- John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, Raine CS, Brosnan CF: Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med. 2002, 8: 1115-1121. 10.1038/nm781.PubMedView ArticleGoogle Scholar
- Wang Y, Cheng X, He Q, Zheng Y, Kim DH, Whittemore SR, Cao QL: Astrocytes from the contused spinal cord inhibit oligodendrocyte differentiation of adult oligodendrocyte precursor cells by increasing the expression of bone morphogenetic proteins. J Neurosci. 2011, 31: 6053-6058. 10.1523/JNEUROSCI.5524-09.2011.PubMedPubMed CentralView ArticleGoogle Scholar
- Sherman LS, Back SA: A 'GAG' reflex prevents repair of the damaged CNS. Trends Neurosci. 2008, 31: 44-52. 10.1016/j.tins.2007.11.001.PubMedView ArticleGoogle Scholar
- Sloane JA, Batt C, Ma Y, Harris ZM, Trapp B, Vartanian T: Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc Natl Adac Sci USA. 2010, 107: 11555-11560. 10.1073/pnas.1006496107.View ArticleGoogle Scholar
- Back SA, Tuohy TM, Chen H, Wallingford N, Craig A, Struve J, Luo NL, Banine F, Liu Y, Chang A, et al: Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med. 2005, 11: 966-972.PubMedGoogle Scholar
- Asher R, Perides G, Vanderhaeghen JJ, Bignami A: Extracellular matrix of central nervous system white matter: demonstration of a hyaluronate-protein complex. J Neurosci Res. 1991, 28: 410-421. 10.1002/jnr.490280314.PubMedView ArticleGoogle Scholar
- Struve J, Maher PC, Li YQ, Kinney S, Fehlings MG, Kuntz Ct, Sherman LS: Disruption of the hyaluronan-based extracellular matrix in spinal cord promotes astrocyte proliferation. Glia. 2005, 52: 16-24. 10.1002/glia.20215.PubMedView ArticleGoogle Scholar
- Wang X, Xu L, Wang H, Zhan Y, Pure E, Feuerstein GZ: CD44 deficiency in mice protects brain from cerebral ischemia injury. J Neurochem. 2002, 83: 1172-1179. 10.1046/j.1471-4159.2002.01225.x.PubMedView ArticleGoogle Scholar
- Craig A, Ling Luo N, Beardsley DJ, Wingate-Pearse N, Walker DW, Hohimer AR, Back SA: Quantitative analysis of perinatal rodent oligodendrocyte lineage progression and its correlation with human. Exp Neurol. 2003, 181: 231-240. 10.1016/S0014-4886(03)00032-3.PubMedView ArticleGoogle Scholar
- Dean JM, Moravec MD, Grafe M, Abend N, Ren J, Gong X, Volpe JJ, Jensen FE, Hohimer AR, Back SA: Strain-specific differences in perinatal rodent oligodendrocyte lineage and its correlation with human. Dev NeurosciGoogle Scholar
- Yang Y, Lewis R, Miller RH: Interactions between oligodendrocyte precursors control the onset of CNS myelination. Dev Biol. 2011, 350: 127-138. 10.1016/j.ydbio.2010.11.028.PubMedPubMed CentralView ArticleGoogle Scholar
- Gadea A, Aguirre A, Haydar TF, Gallo V: Endothelin-1 regulates oligodendrocyte development. J Neurosci. 2009, 29: 10047-10062. 10.1523/JNEUROSCI.0822-09.2009.PubMedPubMed CentralView ArticleGoogle Scholar
- Mi S, Miller RH, Tang W, Lee X, Hu B, Wu W, Zhang Y, Shields CB, Miklasz S, Shea D, Mason J, Franklin RJ, Ji B, Shao Z, Chedotal A, Bernard F, Roulois A, Xu J, Jung V, Pepinsky B: Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann Neurol. 2009, 65: 304-315. 10.1002/ana.21581.PubMedView ArticleGoogle Scholar
- Riddle A, Dean JM, Buser JR, Gong X, Maire J, Chen K, Ahmad T, Chen V, Nguyen T, Kroenke CD, Hohimer AR, Back SA: Histopathological correlates of MRI-defined chronic perinatal white matter injury. Ann Neurol. 2011Google Scholar
- Wolswijk G: Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain. 2002, 125: 338-349. 10.1093/brain/awf031.PubMedView ArticleGoogle Scholar
- Kuhlmann T, Miron V, Cui Q, Wegner C, Antel J, Bruck W: Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain. 2008, 131: 1749-1758. 10.1093/brain/awn096.PubMedView ArticleGoogle Scholar
- Kremer D, Aktas O, Hartung HP, Kury P: The complex world of oligodendroglial differentiation inhibitors. Ann Neurol. 2011, 69: 602-618. 10.1002/ana.22415.PubMedView ArticleGoogle Scholar
- Back SA, Kroenke CD, Sherman LS, Lawrence G, Gong X, Taber ER, Sonnen JA, Larson EB, Montine TJ: White matter lesions defined by diffusion tensor imaging in older adults. Ann Neurol. 2011Google Scholar
- Al Qteishat A, Gaffney JJ, Krupinski J, Slevin M: Hyaluronan expression following middle cerebral artery occlusion in the rat. Neuroreport. 2006, 17: 1111-1114. 10.1097/01.wnr.0000227986.69680.20.PubMedView ArticleGoogle Scholar
- Al'Qteishat A, Gaffney J, Krupinski J, Rubio F, West D, Kumar S, Kumar P, Mitsios N, Slevin M: Changes in hyaluronan production and metabolism following ischaemic stroke in man. Brain. 2006, 129: 2158-2176. 10.1093/brain/awl139.PubMedView ArticleGoogle Scholar
- Marret S, Delpech B, Delpech A, Asou H, Girard N, Courel MN, Chauzy C, Maingonnat C, Fessard C: Expression and effects of hyaluronan and of the hyaluronan-binding protein hyaluronectin in newborn rat brain glial cell cultures. J Neurochem. 1994, 62: 1285-1295.PubMedView ArticleGoogle Scholar
- Polleux F, Ghosh A: The slice overlay assay: a versatile tool to study the influence of extracellular signals on neuronal development. Sci STKE. 2002, 2002: pl9-PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.